Protalix BioTherapeutics, Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2011 | 503.41x | $0.10 | $49.30 |
| Dec 2012 | 139.15x | $0.37 | $51.90 |
| Jun 2013 | 334.67x | $0.12 | $38.90 |
| Dec 2014 | 488.88x | $0.04 | $18.40 |
| Dec 2015 | 233.26x | $0.04 | $10.20 |
| Dec 2016 | 60.72x | $0.07 | $4.50 |
| Dec 2017 | 45.00x | $0.15 | $6.60 |
| Dec 2018 | 1.34x | $2.31 | $3.10 |
| Dec 2019 | 0.89x | $3.69 | $3.28 |
| Dec 2020 | 2.01x | $1.81 | $3.63 |
| Dec 2021 | 0.96x | $0.87 | $0.83 |
| Dec 2022 | 1.39x | $0.98 | $1.37 |
| Dec 2023 | 2.24x | $0.79 | $1.78 |
| Dec 2024 | 2.85x | $0.66 | $1.88 |
| Dec 2025 | 2.59x | $0.67 | $1.74 |